A detailed history of Financial Security Advisor, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Security Advisor, Inc. holds 1,367 shares of AMGN stock, worth $396,293. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,367
Previous 1,403 2.57%
Holding current value
$396,293
Previous $438 Million 0.45%
% of portfolio
0.11%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$309.38 - $337.38 $11,137 - $12,145
-36 Reduced 2.57%
1,367 $440 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $26,012 - $31,611
-99 Reduced 6.59%
1,403 $438 Million
Q1 2024

Apr 18, 2024

SELL
$268.87 - $324.56 $17,476 - $21,096
-65 Reduced 4.15%
1,502 $427 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $6,903 - $7,788
27 Added 1.75%
1,567 $451 Million
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $336,721 - $418,048
1,540 New
1,540 $414 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Security Advisor, Inc. Portfolio

Follow Financial Security Advisor, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Security Advisor, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Security Advisor, Inc. with notifications on news.